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Abstract	  
Biomedical	  research	  owned	  by	  the	  government	  is	  
now	  available	  to	  be	  owned	  by	  private	  ins6tu6ons.	  
This	  results	  in	  stagnant	  innova6ons	  because	  
researchers	  have	  trouble	  with	  all	  the	  restric6ons	  
that	  are	  placed	  by	  private	  ins6tu6ons.	  Priva6za6on	  
of	  biomedical	  research	  has	  short	  term	  posi6ve	  
effects	  but	  its	  nega6ve	  effects	  are	  overarching	  and	  
disastrous.	  One	  way	  to	  combat	  this,	  is	  for	  licenses	  
to	  be	  deployed	  slowly	  with	  future	  consequences	  in	  
mind.	  
Key	  Points	  
•  The	  nature	  of	  federal	  funded	  medical	  research	  
has	  undergone	  a	  profound	  transforma6on.	  
•  Garret	  Harding’s	  term	  “tragedy	  of	  the	  commons”	  
has	  helped	  jus6fy	  priva6za6on.	  
•  Priva6za6on	  has	  increased	  filings	  and	  private	  
investments	  which	  means	  readily	  available	  funds.	  
•  ShiI	  in	  research	  design	  has	  a	  drawback	  termed	  
the	  tragedy	  of	  the	  “an6commons.”	  
•  Brings	  with	  it	  less	  considera6on	  of	  research,	  and	  
more	  focus	  on	  return-­‐on-­‐investments	  
considera6ons.	  	  	  
•  This	  tragedy	  can	  be	  witnessed	  when	  Israel	  try	  to	  




•  Priva6za6on	  has	  short	  term	  benefits	  but	  long	  
term	  disadvantages	  are	  disastrous.	  
•  To	  reduce	  damaging	  effect,	  priva6za6on	  must	  
be	  deployed	  slowly	  and	  carefully.	  
•  Patents	  or	  proprietary	  ownership	  must	  be	  
given	  with	  far	  reaching	  effects	  in	  mind.	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Future	  research	  ideas	  include	  exploring	  the	  
most	  effec6ve	  strategies	  for	  using	  priva6za6on	  
in	  biomedical	  research.	  
	  
	  
Graph	  shows	  the	  decline	  in	  R	  &	  D	  spending	  
by	  the	  federal	  government	  compared	  to	  the	  
private	  sector.	  	  
